Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
---|---|---|---|---|---|
CD2-C52H5 | Cynomolgus | Cynomolgus CD2 / SRBC Protein, His Tag |
|
||
CD2-H82E6 | Human | Biotinylated Human CD2 / SRBC Protein, His,Avitag™ (MALS verified) |
|
||
CD2-H5258 | Human | Human CD2 / SRBC Protein, Fc Tag |
|
||
CD2-H5226 | Human | Human CD2 / SRBC Protein, His Tag (MALS verified) |
|
Loaded Human CD2, Fc Tag (Cat. No. CD2-H5258) on Protein A Biosensor, can bind Human CD58, His Tag (Cat. No. LF3-H5225) with an affinity constant of 2.3 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Siplizumab | MEDI-507; TCD-601 | Phase 2 Clinical | Catholic University Of Louvain, Itb-Med Llc | Rejection of renal transplantation; Diabetes Mellitus, Type 1; Leukemia; Renal Insufficiency; Rejection of liver transplantation; Neoplasms; Myelodysplastic Syndromes; Kidney Diseases; Graft vs Host Disease; Multiple Myeloma; Psoriasis; Lymphoma, T-Cell; Hidradenitis Suppurativa; Lymphoma; Anemia, Sickle Cell; Kidney Failure, Chronic | Details |
Alefacept | LFA-3-TIP; LFA-3(92)IgG; BG-9273; BG-9712; ASP-0485 | Phase 1 Clinical | Astellas Pharma Inc | Diabetes Mellitus, Type 1; Graft vs Host Disease; Psoriasis; Anemia, Aplastic; Lymphoma | Details |
SBT-11-5301 | SBT115301 | Phase 1 Clinical | Sonoma Biotherapeutics Inc | Autoimmune Diseases | Details |
PIT-565 | PIT-565 | Phase 1 Clinical | Novartis Pharma Ag | Lymphoma, B-Cell; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Lupus Erythematosus, Systemic; Leukemia, Myeloid, Acute | Details |
Siplizumab | MEDI-507; TCD-601 | Phase 2 Clinical | Catholic University Of Louvain, Itb-Med Llc | Rejection of renal transplantation; Diabetes Mellitus, Type 1; Leukemia; Renal Insufficiency; Rejection of liver transplantation; Neoplasms; Myelodysplastic Syndromes; Kidney Diseases; Graft vs Host Disease; Multiple Myeloma; Psoriasis; Lymphoma, T-Cell; Hidradenitis Suppurativa; Lymphoma; Anemia, Sickle Cell; Kidney Failure, Chronic | Details |
Alefacept | LFA-3-TIP; LFA-3(92)IgG; BG-9273; BG-9712; ASP-0485 | Phase 1 Clinical | Astellas Pharma Inc | Diabetes Mellitus, Type 1; Graft vs Host Disease; Psoriasis; Anemia, Aplastic; Lymphoma | Details |
SBT-11-5301 | SBT115301 | Phase 1 Clinical | Sonoma Biotherapeutics Inc | Autoimmune Diseases | Details |
PIT-565 | PIT-565 | Phase 1 Clinical | Novartis Pharma Ag | Lymphoma, B-Cell; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Lupus Erythematosus, Systemic; Leukemia, Myeloid, Acute | Details |
This web search service is supported by Google Inc.